Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Post by investryon Sep 24, 2018 10:44am
125 Views
Post# 28676779

RTI (Radient Technologies); ACB( Aurora); KO (Coca-Cola)

RTI (Radient Technologies); ACB( Aurora); KO (Coca-Cola)
Three catalysts for RTI that will solidify deals in my opinion:

 
  1. Obtaining Licensed Producer status
  2. Obtaining Licensed Dealer status 
  3. Expansion Initiatives into Europe or South America

 
When the first or second is realized, I can forsee a deal with ACB and/or KO for beverages and expansion of RTI's extraction efforts for food, health and wellness industries.

"The Company expects that it will receive a Producer’s Licence and a Dealer’s Licence for its Edmonton Manufacturing Facility before the Cannabis Act comes into force on October 17, 2018".

"With one of the world’s largest cannabis cultivators [ACB] as a cornerstone customer and with its capabilities validated, Radient has an industrial-scale, cost-efficient extraction platform that it believes is unique within the cannabis industry globally. As licensed producers across Canada announce large cultivation facility expansions, and as more countries legalize cannabis for medical and adult use, Radient expects that its global growth opportunities will be significant." 


"Radient is finalizing initiatives with respect to expanding its business operations into the European Union...Radient looks forward to working closely with its partners to expand its footprint into Europe in the coming months..."

"Aurora holds an approximately 17% ownership interest in Radiant...The MedReleaf acquisition, upon completion, is expected to be accretive to Radient, as the new combination will require significant additional extraction capacity as can be delivered by Radient through its high throughput technology."

"Christine O'Neil is joining the RTI Global Health and Wellness Solutions team as Senior Vice President, Corporate Development and has been assigned the responsibility of building the RTI Global Health and Wellness brand...she has had the responsibility for managing organizations and developing and launching new business platforms in the health & nutrition, biotechnology and specialty ingredient markets with leading firms such as: The Coca-Cola Company, Nestle, Kellogg, PepsiCo, Wrigley/MARS, Danone, General Mills and many others."

"Jean-Pierre ("JP") Montmayeur joins RTI Global Health and Wellness Solutions as Director, Innovation. JP will be tasked with supporting the build out of the innovation pipeline as well as corporate development activities. His recent role was novel ingredient research as a Senior Scientist at The Cola-Coca Company."


Video: Cam Battley... 

https://www.youtube.com/watch?v=whKnp6DVFLM 
Bullboard Posts